Herbal Medicine for Animal Use in JAPAN

Similar documents
Outline of Risk Analysis for Veterinary Vaccines in Japan

Scientific Discussion post-authorisation update for Rheumocam extension X/007

Risk management of AMR in livestock sector in Japan

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

European Public MRL assessment report (EPMAR)

Approved by the Food Safety Commission on September 30, 2004

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE

drugs, which examine by central competent authorities.

CODE OF PRACTICE TO MINIMIZE AND CONTAIN ANTIMICROBIAL RESISTANCE CAC/RCP Adopted 2005

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

The OIE Relevant Standards and Guidelines for Veterinary Medicinal Products

They're not all the same: Why FDA approval of animal drugs matters

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/12

Action and Experience of Containment of AMR in Veterinary Sector JAPAN

Quality of Veterinary Medicinal Products. How to ensure the quality of Veterinary Medicinal Products

The OIE Relevant Standards and Guidelines for Vaccines

Responsible Use of Veterinary Products. Bettye K. Walters, DVM

MARBOCYL 10% SUMMARY OF PRODUCT CHARACTERISTICS

Human Food Safety of Veterinary Drugs. Bettye K. Walters, DVM

Beef Producers. The Judicious Use of Antimicrobials for

VICH:Organization,Guidelines and Global Outreach

Quality of Veterinary Medicinal Products. How to ensure the quality of Veterinary Medicinal Products

Summary of Product Characteristics

OIE Standards on Veterinary Legislation: Chapter 3.4 of the OIE Terrestrial Animal Health Code

ANNEX III LABELLING AND PACKAGE LEAFLET

ruma Cattle Responsible use of antimicrobials in Cattle production GUIDELINES

All medicinal products (for human and veterinary use) are regulated under the single Pharmaceutical Act.

Guideline on the conduct of efficacy studies for intramammary products for use in cattle

SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Emdocam 20 mg/ml solution for injection for cattle, pigs and horses

Recommended for Implementation at Step 7 of the VICH Process on 15 December 2004 by the VICH Steering Committee

OIE standards on the use of antimicrobials and antimicrobial resistance monitoring

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

SUMMARY OF PRODUCT CHARACTERISTICS. NUFLOR 300 mg/ml solution for injection for cattle and sheep

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

BOX 1. NAME OF THE VETERINARY MEDICINAL PRODUCT. Hymatil 300 mg/ml solution for injection for cattle and sheep Tilmicosin

EXPERIENCE ON ANTIMICROBIAL USE AND RESISTANCE IN KENYA

VETERINARY PRODUCT REGISTRATION

Assessment of compliance of current legislation: Veterinary Products Act

SUMMARY OF PRODUCT CHARACTERISTICS

Illegal veterinary drugs. How to ensure the quality and traceability of Veterinary Medicinal Products

CODE OF PRACTICE TO MINIMIZE AND CONTAIN ANTIMICROBIAL RESISTANCE

Session 1: An introduction to the new requirements under the Food and Drug Regulations affecting industry and health care practitioners who compound

Why? The dairy industry is now under increased drug residue surveillance. Meat and Milk Drug Residues: Current Dairy Industry Topics

General Directorate of Animal Health and EpizooticDiseases Control. Dr.Sabah Hassan Abdelgadir Sudan Focal Point for Veterinary products

For Alberta broiler producers, the biggest impacts will be:

RESIDUE MONITORING AND CONTROL PROGRAM. Dr. T. Bergh Acting Director: Veterinary Public Health Department Agriculture, Forestry and Fisheries

European public MRL assessment report (EPMAR)

REGISTRATION AND REGULATORY CONTROL OF VETERINARY PRODUCTS IN MALAYSIA. National Pharmaceutical Regulatory Agency (NPRA)

About Food Health Impact Assessment

SUMMARY OF PRODUCT CHARACTERISTICS

Legislation on Veterinary Medicinal Products (VMPs) and legal status of relevant VMPs for anesthesia of finfish

Japan. Training Seminar on the OIE PVS Tool for East Asia Seoul, Republic of Korea, April 2016

AMR in Codex Alimentarius Commission and country responsibilities

EXCEDE Sterile Suspension

Snapshot Current Vet Drugs AMR Initiatives

Final Report. Project code: P.PSH.0653 Prepared by: Fiona Cotter Troy Laboratories Pty Ltd Date published: July 2014

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

Results of the questionnaire on Veterinary Medicinal Products in the Middle East Damascus, Syria, 2-4 December 2009

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY of PRODUCT CHARACTERISTICS (SPC)

Livestock Quality Assurance Education for Youth Producers 2017

Summary of Product Characteristics

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Guideline on quality data requirements for veterinary medicinal products intended for minor use or minor species (MUMS)/limited market

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Scientific discussion

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) REVISED GUIDELINE ON THE SPC FOR ANTIMICROBIAL PRODUCTS

GUIDELINE ON LABELLING OF STOCK REMEDIES

SUMMARY OF PRODUCT CHARACTERISTICS

VMP Focal point training Casablanca 6 8 December Dr Susanne Münstermann

Prudent use of antimicrobial agents Dairy Sector Initiatives. Robin Condron Dairy Australia

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

FLOXYME 50 mg/ml SOLUTION FOR USE IN DRINKING WATER

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

A long-acting, broad spectrum, injectable antibiotic for the treatment and control of

Fact Sheet: Veterinary Natural Health Products and CQM

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

mhtml:file://k:\guidemgr\files\2010_fda_compliance Program Manual.mht

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/18

Good clinical practice a tool to refine fish research - an assessors view

Global Food Supply Chain Risks. Antibiotics and the emergence of antibiotic-resistant bacteria in the food chain

Food Safety Act: foods of animal origin other than meat

4.5. Special precautions for use Special precautions to be taken by person administering the veterinary medicinal product to animals

Responsible use of antimicrobials in veterinary practice

Global Overview on Antibiotic Use Policies in Veterinary Medicine

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Guideline on the conduct of efficacy studies for intramammary products for use in cattle

Guideline on the conduct of efficacy studies for intramammary products for use in cattle

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Residues. Mike Apley, DVM, PhD

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

OIE Standards for: Animal identification and traceability Antimicrobials

DIRECTIVE 2001/82/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 6 November 2001 on the Community code relating to veterinary medicinal products

Transcription:

Herbal Medicine for Animal Use in JAPAN Quality Assay Section, Assay Division Ⅱ, National Veterinary Assay Laboratory 21 Dec. 2016 6 Oct. 2016 1

Veterinary Drugs Veterinary Drugs Veterinary Pharmaceuticals Veterinary Biologicals General medicines Antimicrobial medicines Diagnostic reagents Vaccines, Toxoids, Antiserums Herbal medicines Vitamins Hormones Digestive medicines Anti-inflammatory agents Disinfectants / Antiseptics Pesticides for animal etc. 5

Risk Management of Veterinary Drugs Pre Marketing Marketing Approval System Post Marketing. Manufacturing & Quality Control License of the Manufacturer License of the Marketing Authorization Holders Distribution Control License of the Retailer System for Drugs Requiring Veterinary Consultation Prescription system Use Control Restrictions on the Usage of Veterinary Drugs Review of Marketing Approval Reexamination & Reevaluation 9 Reporting Adverse Reactions

Marketing Approval System Nobody can sell veterinary drugs without Marketing Approval. Requirements of the approval License of the Marketing Authorization Holders License of the Manufacturer Management of manufacture conformed to GMP (Good Manufacturing Practice) Data for Marketing Approval Data conformed to GLP(Good Laboratory Practice) Data conformed to GCP(Good Clinical Practice) 10

Data Required for Marketing Approval of a Veterinary Drug in Japan Origin & background of discovery Physicochemical properties Production protocol Stability Toxicity (GLP) Target animal safety (GLP) Veterinary Drug Examination Approval Pharmacological action Residues (GLP) Absorption, Distribution, Metabolism, Excretion Clinical trials (GCP) 11

Data No. Data category (A) New herbal medicine (B) New compositions (C)New administration route (D)New dosage/indications 1 Origin & background of discovery 2 Physicochemical properties 3 Production protocol 5 Stability 6 7 Toxicity Repeat(Chronic etc.) 8 Specific 9 Target animal safety 10 Pharmacological action Efficacy (E) Generic Acute 11 General 12 Absorption, distribution, metabolism & excretion 14 Clinical trial 15 Residue (note) : Data must be attached : It shall not be necessary to attach the data 12 : Data shall not be necessary to attach

Distribution Control System for Drugs Requiring Veterinary Consultation No veterinarian should provide or prescribe poisonous or powerful drugs, etc., without providing consultation by themselves. 1 Poisonous drugs 2 Powerful drugs 3 Biologics (vaccines, serums) 4 Prescription drugs (Vaccines, Antimicrobial medicines, Hormonal products, etc.) 5 Drugs regulated for use on animals (Antimicrobial medicines, Hormonal products) Veterinary drugs used for fish is not included in this system. 13

Prescription System Drug distributor veterinarian 1 Consulting 2 Issue of prescription by the result of diagnosis 3Order by prescription 4 Selling of veterinary drugs Farmer 5 Reasonable and safe use of veterinary drugs Veterinary drugs used for fish is not included in this system. 14

Use Control Restrictions on the Usage of Veterinary Drugs Standards governing restrictions on the usage of veterinary drugs used for food-producing animals to assure public health safety in administration of antimicrobial preparations, etc. to meat or milk-producing animals, poultry, fish/crustacea or bees, to specify drugs that can be used, and their administration, dosages, and prohibition periods for use in the animals concerned. 15

Example of Standards of Restriction for Usage of Veterinary Drugs Drugs Target animal Dosage Ampicillin (in feed) Cattle (not more than 6 months old)) Pigs - Administrate not more than 24 mg/kg bw /day - Administrate not more than 24 mg/kg bw/day Ampicillin level in beef should not exceed its MRL! Chickens - Administrate not more than 40 mg/kg bw/day Prohibition period for use 5 days before slaughter 5 days before slaughter 2 days before slaughter 16 16

Regulation of Veterinary drug Residues in Food Marketing Approval System FSC : ADI (Risk assessment) MHLW : MRL MAFF : Withdrawal Period Establishment of Appropriate Withdrawal Period Distribution Control System for Drugs Requiring Veterinary Consultation Prescription System Appropriate Use of Drugs under the veterinarian's control. Use Control Restrictions on the Usage of Veterinary Drugs These regulations will prevent the veterinary drug over MRL from remaining in food 17

Marketing Approval System FSC MAFF Countermeasures against Antimicrobial Resistance (AMR) : Risk Assessment of AMR : Approval (included specifying method of administration, dose, precautions for use) Distribution Control System for Drugs Requiring Veterinary Consultation Prescription System Use Control Restrictions on the Usage of Veterinary Drugs Other Second Choice Drug System Enlightenment of Prudent Use These regulations will manage AMR 18

Question items:appendix_1.vaccine part 9. How many aquatic vaccines and herbal medicine have been licensed and permitted for using in Japan? Herbal medicine : about 50 products How many batches you have to inspect aquatic vaccine and herbal medicine per year? Herbal medicine : about 0 products (once in several years) 19

Question items:appendix_2 drug part 1. Are there any specified test item in veterinary drugs need to done in registration? (in various dosage forms) See VICH GL39 Test Procedures and Acceptance Criteria for New Veterinary Drug Substances and New Medicinal Products: Chemical Substances (http://www.vichsec.org/guidelines/pharmaceuticals/pharmaquality/pharma-specifications.html) 20

Question items:appendix_2 drug part 2. Does endotoxin test or particulate matter test need to perform in veterinary drugs injections? See VICH GL39 Endotoxins/Pyrogens: A test procedure and acceptance criterion for endotoxins, using a procedure such as the limulus amoebocyte lysate test, should be included in the specification in accordance with regional requirements. Pyrogenicity testing may be proposed as an alternative to endotoxin testing where justified. Japan injection and vehicles attached to preparations, other than those exclusively for intracutaneous, subcutaneous or intramuscular administration 21

See The Japanese Pharmacopoeia 17 th Edition (https://www.pmda.go.jp/files/000213750.pdf) GENERAL RULES FOR PREPARATIONS [3] Monographs for Preparations 3. Preparations for Injection 3-1. Injections (9) Unless otherwise specified, Injections and vehicles attached to preparations other than those used exclusively for intracutaneous, subcutaneous or intramuscular administration meet the requirements of Bacterial Endotoxins Test <4.01>. In the case where the Bacterial Endotoxins Test <4.01> is not applicable, Pyrogen Test <4.04> may be applied instead. 22

Question items:appendix_2 drug part 2. Does endotoxin test or particulate matter test need to perform in veterinary drugs injections? See VICH GL39 Particulate matter: Parenteral products should have appropriate acceptance criteria for particulate matter. This will normally include acceptance criteria for visible particulates and / or clarity of solution, as well as for subvisible particulates as appropriate. Japan Unless otherwise specified, Injections and vehicles attached to preparations meet the requirements of Insoluble Particulate Matter Test for Injections 23

See The Japanese Pharmacopoeia 17 th Edition (https://www.pmda.go.jp/files/000213750.pdf) GENERAL RULES FOR PREPARATIONS [3] Monographs for Preparations 3. Preparations for Injection 3-1. Injections (13) Unless otherwise specified, Injections and vehicles attached to preparations meet the requirements of Foreign Insoluble Matter Test for Injections (14) Unless otherwise specified, Injections and vehicles attached to preparations meet the requirements of Insoluble Particulate Matter Test for Injections 24

Question items:appendix_2 drug part 3. Can you provide animal drug regulations about unqualified products of control and punishment? Nobody can sell veterinary drugs without marketing approval. The user must observe Standards governing restrictions on the usage of veterinary drugs used for food-producing animals. Nobody can use anything other than veterinary drugs which have been already approved to foodproducing animals. Punishment : Penal servitude three years or less, penalty that is less than 3 million yen or both 25

Question items:appendix_2 drug part 4. Are there any aquatic animal drug or formulas had been approved especially for using in ornamental fish and food fish? See following site (food fish) (http://www.maff.go.jp/j/syouan/suisan/suisan_yobo/pdf/29.pdf) 29

See following site (ornamental fish) (http://www.maff.go.jp/j/syouan/suisan/suisan_yobo/pdf/29.pdf) (http://www.nval.go.jp/asp/asp_dbdr_idx.asp) 30

Question items:appendix_2 drug part 5. Can you provide Japanese aquatic animal drug or formulas inspection standards about executing value effect, toxicological tests, and drugs residue tests etc. to us? And also, do testing fish type is object of host fish or other typical fish to do the tests? See VICH web site (http://www.vichsec.org/) NVAL Home Page (http://www.maff.go.jp/nval/hourei_tuuti/pdf/160805_betten2.pdf) 31

Question items:appendix_2 drug part 7. Are there any traditional medicine (like herbs or traditional Chinese medicine) already using in veterinary drugs? How about the regulation on registration, test item or reference? Yes As stated above 32

Question items:appendix_2 drug part 9. Is the disinfectant for farm used outlined in animal drugs or environmental drugs? And, does this disinfectant used for specific virus (for instant AI, ND, FMD etc.) to do killing tests? If you do, could you provide your testing references to us? The disinfectant for animal farm used is outlined in animal drugs. usually No, if necessary Yes, but in vitro test only. We cannot provide you the data which were submitted by an applicant. 33

Thank you for your attention!!